Antiretroviral therapies block HIV replication but they do not eliminate inactive viruses within cells. A clinical trial shows that a drug can revive HIV in patients as a potential first step towards a cure. See Letter p.482
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Nature Communications Open Access 22 June 2023
-
Tigliane and daphnane diterpenoids from Thymelaeaceae family: chemistry, biological activity, and potential in drug discovery
Journal of Natural Medicines Open Access 09 June 2023
-
SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells
Nature Communications Open Access 19 August 2022
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Richman, D. D. et al. Science 323, 1304–1307 (2009).
Trono, D. et al. Science 329, 174–180 (2010).
Archin, N. M. et al. Nature 487, 482–485 (2012).
Siliciano, J. D. et al. Nature Med. 9, 727–728 (2003).
Archin, N. M. et al. AIDS Res. Hum. Retroviruses 25, 207–212 (2009).
Contreras, X. et al. J. Biol. Chem. 284, 6782–6789 (2009).
Blazkova, J. et al. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jis412 (2012).
Shan, L. et al. Immunity 36, 491–501 (2012).
Hansen, S. G. et al. Nature 473, 523–527 (2011).
Persaud, D. et al. AIDS 25, 2227–2234 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has received grant support from Merck, a pharmaceutical company that produces the drug vorinostat.
Rights and permissions
About this article
Cite this article
Deeks, S. Shock and kill. Nature 487, 439–440 (2012). https://doi.org/10.1038/487439a
Published:
Issue Date:
DOI: https://doi.org/10.1038/487439a
This article is cited by
-
Tigliane and daphnane diterpenoids from Thymelaeaceae family: chemistry, biological activity, and potential in drug discovery
Journal of Natural Medicines (2023)
-
Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir
Archives of Virology (2023)
-
Development trends of immune activation during HIV infection in recent three decades: a bibliometric analysis based on CiteSpace
Archives of Microbiology (2023)
-
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
Nature Communications (2023)
-
Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models
Retrovirology (2022)